Leshan Giantstar Farming&Husbandry (603477)

Search documents
巨星农牧(603477) - 乐山巨星农牧股份有限公司第四届董事会第二十六次会议决议公告
2025-04-25 12:06
| 证券代码:603477 | 证券简称:巨星农牧 | 公告编号:2025-035 | | --- | --- | --- | | 债券代码:113648 | 债券简称:巨星转债 | | 乐山巨星农牧股份有限公司 第四届董事会第二十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、会议召开情况 乐山巨星农牧股份有限公司(以下简称"公司")第四届董事会第二十六次会议 于 2025 年 4 月 25 日以现场结合通讯方式召开。本次会议的会议通知于 2025 年 4 月 22 日分别以专人送达、电子邮件或传真等方式发出,会议由公司董事长段利锋先 生召集并主持,应到董事 9 人,实到董事 9 人,公司全体监事、高级管理人员及高 级管理人员候选人列席了本次会议。会议的召集、召开符合有关法律、行政法规、 部门规章和《公司章程》的规定。 二、会议审议情况 (一)审议通过了《公司2025年第一季度报告》 审议通过了《公司2025年第一季度报告》,并进行相关公告。 具体内容详见同日于上海证券交易所网站(http://sse. ...
巨星农牧:2025一季报净利润1.3亿 同比增长194.2%
Tong Hua Shun Cai Bao· 2025-04-25 11:16
前十大流通股东累计持有: 32283.5万股,累计占流通股比: 63.29%,较上期变化: -89.19万股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.2500 | -0.2700 | 192.59 | -0.4100 | | 每股净资产(元) | 6.22 | 5.32 | 16.92 | 6.35 | | 每股公积金(元) | 4.51 | 4.51 | 0 | 4.37 | | 每股未分配利润(元) | 1.26 | -0.25 | 604 | 0.92 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 16.45 | 9.49 | 73.34 | 8.94 | | 净利润(亿元) | 1.3 | -1.38 | 194.2 | -2.06 | | 净资产收益率(%) | 3.88 | -4.60 | 184.35 | -5.76 | 数据四舍五入,查看更多财务数据>> ...
巨星农牧(603477) - 2025 Q1 - 季度财报
2025-04-25 11:00
Financial Performance - The company's operating revenue for the first quarter reached CNY 1,645,357,655.95, representing a 73.45% increase compared to the same period last year[4] - Net profit attributable to shareholders was CNY 129,645,889.86, a significant turnaround from a loss of CNY 138,047,904.89 in the previous year, marking a 193.91% increase[4] - The net cash flow from operating activities surged to CNY 258,345,555.32, up 2,865.67% from CNY 8,711,207.41 in the same quarter last year[4] - Basic and diluted earnings per share improved to CNY 0.25, compared to a loss of CNY 0.27 per share in the previous year, reflecting a 192.59% increase[5] - The weighted average return on equity rose to 3.88%, an increase of 8.48 percentage points from -4.60% in the previous year[5] - The net profit excluding non-recurring gains and losses was CNY 132,275,766.45, a 217.81% increase from a loss of CNY 112,275,152.48 in the same period last year[4] - Total operating revenue for Q1 2025 reached ¥1,645,357,655.95, a significant increase of 73.5% compared to ¥948,632,662.53 in Q1 2024[18] - Net profit for Q1 2025 was ¥130,952,181.52, compared to a net loss of ¥137,748,137.54 in Q1 2024, marking a turnaround[19] - Basic and diluted earnings per share for Q1 2025 were both ¥0.25, compared to a loss of ¥0.27 per share in Q1 2024[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 9,255,157,188.82, a 5.60% increase from CNY 8,764,113,124.65 at the end of the previous year[5] - The company's current assets reached RMB 3,373,305,255.96, up from RMB 2,863,933,360.71, indicating a significant increase of about 17.8%[14][16] - The inventory value rose to RMB 2,506,949,149.24 from RMB 2,092,577,839.97, representing an increase of approximately 19.8%[14][16] - Short-term borrowings increased to RMB 1,392,567,654.74 from RMB 1,058,372,144.31, marking a rise of about 31.5%[16] - The total liabilities of the company were RMB 5,819,268,738.98, compared to RMB 5,425,519,656.18, which is an increase of approximately 7.3%[16] - The equity attributable to the parent company reached RMB 3,396,512,765.30, up from RMB 3,300,524,075.59, reflecting a growth of about 2.9%[16] Cash Flow - The company's cash and cash equivalents stood at RMB 614,769,342.42, an increase from RMB 576,863,694.94, showing a growth of approximately 6.6%[14][16] - Cash flow from operating activities for Q1 2025 was ¥258,345,555.32, a substantial increase from ¥8,711,207.41 in Q1 2024[22] - Cash received from sales of goods and services in Q1 2025 was ¥1,571,184,697.86, compared to ¥923,311,484.33 in Q1 2024, reflecting a growth of 70.4%[22] - Total cash outflow from operating activities in Q1 2025 was ¥1,575,229,917.17, compared to ¥943,163,666.46 in Q1 2024[22] Investment and Financing Activities - The company reported non-recurring losses of CNY 2,629,876.59, primarily due to asset disposal losses and government grants[7] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[20] - The net cash flow from investing activities was -$247.93 million, compared to -$239.61 million in the previous period, indicating a slight increase in cash outflow for investments[23] - Cash inflow from financing activities totaled $773.20 million, up from $526.82 million, reflecting a significant increase in financing received[23] - Cash outflow for debt repayment was $604.66 million, which is a substantial increase from $259.70 million in the prior period[23] - The total cash outflow for investment activities was $313.78 million, compared to $274.17 million, indicating increased investment in fixed and intangible assets[23] - The company received $150.20 million from other financing activities, a significant increase from $23.79 million, highlighting enhanced capital raising efforts[23] Other Financial Metrics - The company reported a significant increase in prepayments, which rose to RMB 125,418,992.98 from RMB 77,744,509.98, representing an increase of approximately 61.2%[14][16] - The accounts receivable increased to RMB 90,474,813.84 from RMB 67,528,121.53, indicating a rise of about 33.8%[14][16] - The long-term borrowings decreased to RMB 256,851,280.02 from RMB 451,220,425.36, indicating a reduction of about 43%[16] - The cash flow impact from exchange rate changes was -$211,764.42, slightly worse than the previous period's -$132,112.24, indicating currency volatility effects[23] - The cash outflow related to other financing activities was $145.78 million, compared to $66.34 million, indicating a rise in associated costs[23]
巨星农牧(603477) - 乐山巨星农牧股份有限公司关于2025年度对外担保授权的公告
2025-04-25 10:56
| 证券代码:603477 | 证券简称:巨星农牧 | 公告编号:2025-036 | | --- | --- | --- | | 债券代码:113648 | 债券简称:巨星转债 | | 乐山巨星农牧股份有限公司 关于 2025 年度对外担保授权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 被担保人名称:乐山巨星农牧股份有限公司(以下简称"公司"、"巨星农 牧"或"上市公司")下属各子公司及下属子公司的优质客户、养殖户、合 作伙伴等,非公司关联方。 公司拟提供担保的总额度不超过 548,000.00 万元(含存量担保额度,在该 担保总额度内循环使用),其中公司对下属各子公司提供担保总额不超过 505,300.00 万元;公司全资子公司巨星农牧有限公司(以下简称"巨星有限") 对其下属各子公司提供担保总额不超过 19,000.00 万元,公司对其下属各子 公司的优质养殖户、客户、合作伙伴等提供担保总额不超过 22,500.00 万元, 公司全资子公司巨星有限对其下属各子公司的优质养殖户、客户、合作伙伴 ...
巨星农牧(603477) - 乐山巨星农牧股份有限公司关于开展商品期货套期保值业务的公告
2025-04-25 10:56
| 证券代码:603477 | 证券简称:巨星农牧 | 公告编号:2025-038 | | --- | --- | --- | | 债券代码:113648 | 债券简称:巨星转债 | | 乐山巨星农牧股份有限公司 关于开展商品期货套期保值业务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 交易目的:公司是集种猪、商品猪、饲料生产于一体的企业,为防范和规 避原材料价格和生猪价格波动风险,促进乐山巨星农牧股份有限公司(以下简 称"公司")和全资及控股子公司的经营稳定发展,公司拟使用自有资金开展 商品期货套期保值业务。 交易品种、交易工具、交易场所:公司将在合法合规的场内或场外交易场 所开展商品期货套期保值业务,业务包括但不限于期货、期权等合约交易,品 种仅限于与公司生产经营相关的产品或者所需的原材料,前述产品、原材料包 括但不限于"生猪、玉米、豆粕、豆油"等。 交易金额:公司开展商品期货套期保值业务所需保证金和权利金最高占用 额不超过人民币 2.5 亿元(不含期货标的实物交割款项),有效期内可循环使 用。 ...
巨星农牧(603477) - 乐山巨星农牧股份有限公司2025年度日常关联交易预计公告
2025-04-25 10:56
| | | 乐山巨星农牧股份有限公司 2025 年度日常关联交易预计公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 该事项无需提交股东大会审议。 日常关联交易对上市公司的影响:乐山巨星农牧股份有限公司(以下简 称"公司")与关联人的日常关联交易系基于各公司生产经营需要确定的,关联 交易自愿平等公允,不会损害公司和股东利益,特别是中小股东利益,不会对关 联方形成较大的依赖,也不会影响公司正常生产经营。 一、日常关联交易基本情况 (一)日常关联交易履行的审议程序 2025 年 4 月 25 日,公司第四届董事会第二十六次会议审议通过了《关于公 司 2025 年度日常关联交易预计的议案》,同意公司 2025 年日常关联交易预计事 项。 本年度日常关联交易预计无需提交股东大会审议。 独立董事专门会议已对此交易进行了审议,全体独立董事一致同意,专门会 议审核意见如下:公司决策程序符合法律、行政法规、部门规章及其他规范性法 律文件和《公司章程》、《关联交易管理制度》的规定;关联交易合理、合法, 价格公允,未发现损害公 ...
巨星农牧(603477) - 乐山巨星农牧股份有限公司关于开展商品期货套期保值业务的可行性分析报告
2025-04-25 10:56
一、开展套期保值业务的背景和目的 公司是集种猪、商品猪、饲料生产于一体的企业,为防范和规避原材料价格和 生猪价格波动风险,促进乐山巨星农牧股份有限公司(以下简称"公司")和全资 及控股子公司的经营稳定发展,进而提升公司整体抵御风险能力,公司拟使用自有 资金开展商品期货套期保值业务。 二、开展套期保值业务基本情况 (一)交易目的 公司是集种猪、商品猪、饲料生产于一体的企业,为防范和规避原材料价格和 生猪价格波动风险,促进乐山巨星农牧股份有限公司(以下简称"公司")和全资 及控股子公司的经营稳定发展,进而提升公司整体抵御风险能力,公司拟使用自有 资金开展商品期货套期保值业务。 (二)交易金额 公司开展商品期货套期保值业务所需保证金和权利金最高占用额不超过人民币 2.5亿元(不含期货标的实物交割款项),有效期内可循环使用。 (三)资金来源 (一)主要风险分析 公司开展商品期货套期保值业务不以投机为目的,主要为有效规避原材料、产 成品价格波动对公司经营带来的潜在不利影响,但同时也会存在一定的"市场风险、 流动性风险、资金风险、内部控制风险、技术风险、政策风险"等如下主要风险: 1、市场风险:原料、产品等价格行情变动较 ...
巨星农牧(603477) - 乐山巨星农牧股份有限公司关于提请股东大会授权董事会办理小额快速融资相关事宜的公告
2025-04-25 10:56
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 乐山巨星农牧股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召开 了第四届董事会第二十六次会议,审议通过了《关于提请股东大会授权董事会办 理小额快速融资相关事宜的议案》,前述议案尚需提交 2024 年年度股东大会审 议。 为提高公司股权融资决策效率,根据《上市公司证券发行注册管理办法》(以 下简称"《注册管理办法》")《上海证券交易所上市公司证券发行上市审核规 则》《上海证券交易所上市公司证券发行与承销业务实施细则》等相关规定,公 司董事会提请股东大会授权董事会决定公司以简易程序向特定对象发行融资总 额不超过人民币 3 亿元且不超过最近一年末净资产 20%的股票,授权期限为 2024 年年度股东大会审议通过之日起至 2025 年年度股东大会召开之日止。本议案尚 需提交公司 2024 年年度股东大会审议。 本次授权事宜包括以下内容: 1、确认公司是否符合以简易程序向特定对象发行股票(以下简称"小额快 速融资")的条件 | 证券代码:603477 | 证券简称:巨星 ...
巨星农牧(603477) - 乐山巨星农牧股份有限公司关于以集中竞价方式回购股份的回购报告书
2025-04-24 13:41
| 证券代码:603477 | 证券简称:巨星农牧 | 公告编号:2025-034 | | --- | --- | --- | | 债券代码:113648 | 债券简称:巨星转债 | | 乐山巨星农牧股份有限公司 关于以集中竞价方式回购股份的回购报告书 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ● 回购股份金额:本次回购股份的资金总额不低于人民币 5,000 万元(含) 且不超过人民币 10,000 万元(含) ● 回购股份资金来源:公司自有资金和金融机构借款。公司于近日收到兴业 银行股份有限公司成都分行出具的《贷款承诺函》,借款金额不超过人民币 0.9 亿元,贷款期限不超过 3 年,借款专项用于公司股份回购。 ● 回购股份用途:用于员工持股计划或股权激励 ● 回购股份价格:不超过人民币 28.00 元/股 ● 回购股份方式:集中竞价交易方式 ● 回购股份期限:自公司董事会审议通过本次回购股份方案之日起 12 个月 内 ● 相关股东是否存在减持计划:经问询,截至本公告披露日,公司董监高、 控股股东、实 ...
农林牧渔行业周报:生猪行业养殖利润稳定,牛价延续强势运行
Minsheng Securities· 2025-04-24 00:23
Investment Rating - The report maintains a "Recommended" investment rating for the industry, suggesting a potential upside of over 15% relative to benchmark indices [4]. Core Insights - The swine industry shows stable breeding profits, with a focus on capacity reduction logic. The average price of external three yuan pigs was 15.0 CNY/kg, up 2.1% week-on-week, while the average weight of pigs sold was 128.6 kg, down 0.2% [19][20]. - The beef industry is at an inflection point, with strong price performance continuing. The average price of calves was 28.2 CNY/kg, up 2.1%, and the average price of fattened cattle was 25.8 CNY/kg, up 0.7% [23][30]. - The white chicken market is affected by ongoing avian influenza, with significant impacts on breeding stock and prices. The average price of white feather broiler chicks was 2.8 CNY/chick, up 9.5% [31][34]. - The animal health sector is seeing a recovery in demand as breeding supply stabilizes, with a notable increase in the issuance of vaccines [48][49]. Summary by Sections Swine Industry - The average price of external three yuan pigs was 15.0 CNY/kg, reflecting a week-on-week increase of 2.1%. The average weight of pigs sold was 128.6 kg, down 0.2%. The price of 15 kg external three yuan piglets was 668 CNY/head, with a slight decrease of 0.05% [19][21]. - Supply pressure remains stable, with normal sales rhythms from large producers and limited sales from smallholders. The demand side shows increased activity from secondary breeding, but overall consumption remains weak [20][21]. - The report recommends companies such as Muyuan Foods, Wens Foodstuff Group, and New Hope Liuhe for investment [20]. Beef Industry - The beef breeding industry is entering a capacity release phase, with the earliest signs of a price bottom forming. The report anticipates a potential recovery in the industry by late 2025 or early 2026 [23][30]. - The average wholesale price of beef was 61.4 CNY/kg, reflecting a slight increase of 0.2% [29][30]. - Recommended companies include Fucheng Co. and Guangming Meat Industry, focusing on integrated breeding and sales [23]. Poultry Industry - The average price of white feather broiler eggs was 1.6 CNY/egg, up 2.0%, while the average price of white feather broilers was 3.7 CNY/kg, up 2.2% [31][34]. - The report highlights the impact of avian influenza on breeding imports, particularly from the U.S. and New Zealand, which has been suspended for over three months [31][32]. - Recommended companies include Yisheng Livestock and He Feng Food [31]. Animal Health Sector - The demand for animal health products is expected to recover as breeding supply stabilizes. The issuance of vaccines has shown significant increases, particularly for swine diseases [48][49]. - The report recommends companies like Kexin Biological and Zhongmu Biotechnology, which are positioned to benefit from the recovery in the animal health market [49].